p.135 抽出テキスト

2) Imanaka K, Tominaga Y, Etropolski M, et al. Ready conversion of patients with well‒con­ trolled, moderate to severe, chronic malignant tumor‒related pain on other opioids to tapen­ tadol extended release. Clin Drug Investig 2014;34:501‒11 3) Kress HG, Koch ED, Kosturski H, et al. Tapentadol prolonged release for managing moderate

to severe, chronic malignant tumor‒related pain. Pain Physician 2014;17:329‒43